PHSI Designs MAC Pricing Benefiting HMO and Retail Pharmacy
| Industry | Managed Care/ PBM |
| Problem | A Medicaid HMO wanted to ensure that their Maximum Allowable Cost (MAC) list was controlling generic expenditures while providing a reasonable profit to their retail pharmacy networks. |
| PHSI Solution | PHSI created a unique model to analyze the costs associated with generic drugs in order to create competitive MAC lists incorporating the needs of all market segments. The MAC list aligned incentives for all stakeholders to promote generic substitution. |
| Results | The Medicaid HMO aligned financial incentives while increasing their generic substitution rate and lowering network complaints on generic pricing. |
Poll Results
June 2020 Question of the Month
What percent of drug manufacturers will increase production of drug products in the US?
0%: 0%
1-10%: 14%
11-20%: 43%
21-30%: 29%
More than 30%: 14%
May 2020 Question of the Month
When do you feel that a COVID-19 vaccine will become available?
Less than 12 months: 8.3%
12 to 18 months: 66.7%
18 to 24 months: 25.0%
More than 24 months: 0%
Never: 0%
March 2020 Question of the Month
What impact will the coronavirus (COVID-19) have on the pharmaceutical supply chain due to API sourced from China?
High impact: 73%
Some impact: 18%
Low impact: 9%
No impact: 0%
Contact
968 Perry Highway
Pittsburgh, PA 15237
Get Directions »
Phone: (412) 635-4650
Follow/Subscribe:
